Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Population-Based Birth-Year Cohort
Genetics
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Population-Based Birth-Year Cohort

28, Jan 2026

2
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Population-Based Birth-Year Cohort
Genetics
Role of Rare Genetic Variants in Multiple Sclerosis Pathogenesis

27, Jan 2026

3
Quantifying Polygenic Risk in Multiple Sclerosis: Insights from Familial Genetic Burden Analysis
Genetics
Quantifying Polygenic Risk in Multiple Sclerosis: Insights from Familial Genetic Burden Analysis

26, Jan 2026

4
Gene–Environment Interactions in Multiple Sclerosis: Evidence from Polygenic Risk
Genetics
Gene–Environment Interactions in Multiple Sclerosis: Evidence from Polygenic Risk

25, Jan 2026

5
Genetic Risk Stratification in Optic Neuritis: Advancing Early Prediction of Multiple Sclerosis
Genetics
Genetic Risk Stratification in Optic Neuritis: Advancing Early Prediction of Multiple Sclerosis

23, Jan 2026

Categories:
Genetics
Moving Beyond "One Drug Fits All" in Multiple Sclerosis: The Dawn of Personalized Medicine
Genetics
Moving Beyond "One Drug Fits All" in Multiple Sclerosis: The Dawn of Personalized Medicine

27, Apr 2025

Decoding MS Treatment Response: Could Our Genes Hold the Key to Better Outcomes with Glatiramer Acetate?
Genetics
Decoding MS Treatment Response: Could Our Genes Hold the Key to Better Outcomes with Glatiramer Acetate?

28, Apr 2025

Multiple Sclerosis Treatment Response and the Role of Genetic Variations
Genetics
Multiple Sclerosis Treatment Response and the Role of Genetic Variations

29, Apr 2025

Genetic Variations Influencing Glatiramer Acetate Response in Multiple Sclerosis: A Pharmacogenomic Perspective
Genetics
Genetic Variations Influencing Glatiramer Acetate Response in Multiple Sclerosis: A Pharmacogenomic Perspective

30, Apr 2025